Quiz For DJR-128
Quiz Summary
0 of 8 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
0 of 8 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- DJR-128 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- Current
- Review
- Answered
- Correct
- Incorrect
-
Question 1 of 8
1. Question
Based on the published literature cited in this study, what is most important prognostic factor affecting survival in patients with NETs?
CorrectIncorrect -
Question 2 of 8
2. Question
Based on the multivariate analyses described in this study, which one of the following factor remained as a significant factor for poor survival after TARE?
CorrectIncorrect -
Question 3 of 8
3. Question
True or false? Based on the results described herein, the levels of alkaline phosphatase (ALP), aspartate transaminase (AST), and alanine transaminase (ALT) demonstrated an increasing trend over a 1-year period after the TARE that remained statistically significant even after adjusting for baseline tumor characteristics.
CorrectIncorrect -
Question 4 of 8
4. Question
True or false? Elevations in ALP and AST over baseline normalized over the 4-year period.
CorrectIncorrect -
Question 5 of 8
5. Question
Based on the results reported herein, what was the approximate median survival after TARE in patients without extrahepatic disease?
CorrectIncorrect -
Question 6 of 8
6. Question
Y90 radioembolization is a safe and promising treatment option for unresectable NET liver metastases that is associated with low rates of severe long-term serologic toxicities.
CorrectIncorrect -
Question 7 of 8
7. Question
Serologic toxicity is not a major concern after any interventional treatment for liver metastases.
CorrectIncorrect -
Question 8 of 8
8. Question
According to the study, therapies received before or after Y90 radioembolization may have contributed to long-term toxicities.
CorrectIncorrect